gaining weight after glp 1 Two Years Stopping GLP-1s, Most Patients Sustain at Least Some Loss I've been off GLP1 since

You receive a full cost breakdown before committing to anything

Reddys Laboratories has launched Obeda, semaglutide injection following approval from the Drugs Controller General of India (DCGI), marking its entry into the fast-growing GLP-1 receptor agonist therapy segment

Demand for GLP-1 receptor agonists is estimated to be valued at USD 2.9 billion in 2026

These effects are mediated by: Improved endothelial function and nitric oxide bioavailability Reduced vascular inflammation and oxidative stress Stabilization of atherosclerotic plaque Enhanced cardiac metabolism and mitochondrial efficiency From a longevity standpoint, microdosing may maintain low-grade GLP-1 receptor activation within vascular tissue, supporting arterial flexibility, autonomic tone, and lipid regulation without the gastrointestinal intolerance often limiting high-dose use